Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed COO

Kaleido Biosciences, Inc. (KLDO) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/02/2022 4 van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Paid exercise price by delivering 2,087 restricted stock units @ $1.49, valued at $3.1k
03/02/2022 4 Korn Jerald (COO & General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Paid exercise price by delivering 2,046 restricted stock units @ $1.49, valued at $3k
01/18/2022 4 van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 350,000 restricted stock units @ $0
01/18/2022 4 Long Alison S (Chief Medical Officer) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 46,800 restricted stock units @ $0
Granted 125,000 restricted stock units @ $0
01/18/2022 4 Korn Jerald (COO & General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 45,240 restricted stock units @ $0
Granted 250,000 restricted stock units @ $0
01/18/2022 4 Duke William E. (CFO) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 44,990 restricted stock units @ $0
Granted 125,000 restricted stock units @ $0
01/18/2022 4 Menichella Daniel L (CEO) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 70,200 restricted stock units @ $0
Granted 250,000 restricted stock units @ $0
12/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
09/02/2021 4 van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 40,000 options to buy @ $6.29, valued at $251.6k
09/02/2021 4 Korn Jerald (General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 100,000 options to buy @ $6.29, valued at $629k
09/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2021 4 Burnett Grady (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $7.44, valued at $111.6k
07/01/2021 4 Bassler Bonnie L (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $7.44, valued at $111.6k
07/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2021 4 Mixer Jean K (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $7.44, valued at $111.6k
07/01/2021 4 Prener Anne (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $7.44, valued at $111.6k
07/01/2021 4 BONNEY MICHAEL W (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $7.44, valued at $111.6k
Granted 15,000 options to buy @ $0
07/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2021 4 von Maltzahn Geoffrey (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $7.44, valued at $111.6k
05/13/2021 3 van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 3 on Kaleido Biosciences, Inc.
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Korn Jerald (General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 60,000 options to buy @ $9.81, valued at $588.6k
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/19/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/01/2020 4 von Maltzahn Geoffrey (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $7.43, valued at $111.5k
07/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy